Lumigan (bimatoprost) — First-Time Generic

Lumigan? (bimatoprost) -- First-Time Generic ? On February 23, 2015, Lupin announced the FDA approval of its AT-rated generic to Allergan's

Lumigan (bimatoprost) 0.03% ophthalmic solution, for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension.

-- Brand Lumigan 0.03% is no longer commercially available. -- Brand Lumigan is available as a 0.01% ophthalmic solution and has the same indication as the

0.03% ophthalmic solution. Generics are not available for the 0.01% strength. ? Bimatoprost is also available as a 0.03% ophthalmic solution (Latisse?) to treat hypotrichosis of the

eyelashes by increasing their growth including length, thickness and darkness. ? Lupin plans to launch generic Lumigan 0.03% ophthalmic solution soon.

OptumRx specializes in the delivery, clinical management and affordability of prescription medications and consumer health products. We are an OptumTM company -- a leading provider of integrated health services. Learn more at . All OptumTM trademarks and logos are owned by Optum, Inc. All other brand or product names are trademarks or registered marks of their respective owners. ?2014 Optum, Inc. All rights reserved.

 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download